Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **bacterial RNA polymerase beta subunit** (commonly referred to as the **β subunit** or **RpoB**) is one of the core subunits of the bacterial DNA-dependent RNA polymerase enzyme complex, which catalyzes the synthesis of RNA from a DNA template during transcription[3][7][8]. The β subunit, encoded by the rpoB gene, forms part of the catalytic center with the β′ subunit and provides key sites for the binding of DNA, nascent RNA, and for the action of crucial antibiotics[3][8]. It is a major target of rifampicin and related drugs, and specific mutations in rpoB lead to drug resistance, making it clinically significant for the treatment and monitoring of bacterial infections, especially tuberculosis[3]. The β subunit’s structure plays a central role in coordinating catalytic activity, facilitating nucleic acid interactions, and interacting with transcriptional regulators and inhibitors[5][7][8].
Inhibition of RNA synthesis by binding to the beta subunit and blocking the formation of the RNA chain (e.g., rifampicin binds to β subunit, preventing elongation of RNA transcript)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA polymerase beta subunit (bacterial) (β subunit (bacterial RNAP) or RpoB).